Table 1 Abnormal lab results on hospital admission
From: COVID-19-associated MRSA infective endocarditis and mitral valve perforation: a case report
Laboratory tests | On admission | Reference range |
|---|---|---|
CBC without differential | ||
Hemoglobin (g/dL) | 10.4 | 13.2–16.6 |
Hematocrit (%) | 31.5 | 38.3–48.6 |
Erythrocytes (× 1012/L) | 3.74 | 4.35–5.65 |
RBC distribution width (%) | 14.8 | 11.8–14.5 |
Platelet count (× 109/L) | 330 | 135–317 |
Leukocytes (× 109/L) | 10.4 | 3.4–9.6 |
Coagulation profile | ||
Activated partial thromboplastin time (APTT) (s) | 56 | 25–37 |
Hepatic function panel | ||
Aspartate aminotransferase (AST) (U/L) | 54 | 8–48 |
Albumin (g/dL) | 2.8 | 3.5–5.0 |
Protein, total (g/dL) | 5.6 | 6.3–7.9 |
Basic metabolic panel | ||
Sodium (mmol/L) | 129 | 135–145 |
Calcium, total (mg/dL) | 8.1 | 8.8–10.2 |
Glucose (mg/dL) | 169 | 70–140 |
Anion gap | 6 | 7–15 |
Creatinine (mg/dL) | 0.63 | 0.74–1.35 |